Rigel Pharmaceuticals reported $54.96M in Current Liabilities for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Liabilities Change
Agenus AGEN:US $ 159.72M 3.34M
Amgen AMGN:US $ 12618M 268M
Anika Therapeutics ANIK:US $ 29.43M 2.44M
Applied Genetic Technologies AGTC:US $ 25.21M 0.6M
Arrowhead Research ARWR:US $ 128.21M 10.64M
AstraZeneca AZN:LN 1791796.84M 60282.28M
Astrazeneca AZN:US $ 21815M 925M
Biomarin Pharmaceutical BMRN:US $ 464.73M 25.69M
Bristol Myers Squibb BMY:US $ 20915M 1906M
Celldex Therapeutics CLDX:US $ 29.95M 15.39M
Chemocentryx CCXI:US $ 76.08M 7.27M
Daiichi Sankyo 4568:JP Y 406816M 11548M
Eli Lilly And LLY:US $ 15620.6M 2234.6M
Halozyme Therapeutics HALO:US $ 199.51M 87.82M
Heron Therapeutics HRTX:US $ 109.5M 16.5M
Immunogen IMGN:US $ 87.07M 2.95M
Intrexon XON:US $ 29.9M 4.3M
IONIS PHARMACEUT IONS:US $ 267.81M 39.36M
Karyopharm Therapeutics KPTI:US $ 62.54M 3.8M
Ligand Pharmaceuticals LGND:US $ 167.85M 125.28M
Macrogenics MGNX:US $ 50.88M 16.22M
Neurocrine Biosciences NBIX:US $ 285.7M 32.2M
Regeneron Pharmaceuticals REGN:US $ 3033.9M 26.3M
Rigel Pharmaceuticals RIGL:US $ 54.96M 4.27M
Sangamo Biosciences SGMO:US $ 119.99M 1.46M
Ultragenyx Pharmaceutical RARE:US $ 220.64M 53.4M
Veracyte VCYT:US $ 59.34M 3.2M